Can-Fite BioPharma Ltd. (CANF) Operating cash flow 2017–2025
Can-Fite BioPharma Ltd. (CANF) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$8.9MFY2025 · since FY2017: -$9.0M → -$8.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$8.9M | -17.2% |
| FY2024 | -$7.6M | +9.5% |
| FY2023 | -$8.4M | +21.9% |
| FY2022 | -$10.8M | -9.6% |
| FY2021 | -$9.9M | +18.3% |
| FY2020 | -$12.1M | -8.8% |
| FY2019 | -$11.1M | -166.8% |
| FY2018 | -$4.2M | +53.7% |
| FY2017 | -$9.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CANF financial trends
CANF RevenueCANF Net incomeCANF Net marginCANF Gross profitCANF Gross marginCANF Operating incomeCANF Operating marginCANF Free cash flowCANF Capital expendituresCANF Return on equityCANF Stock buybacksCANF Dividends paidCANF Total assetsCANF Total liabilitiesCANF Shareholders’ equityCANF overview →